Global Blood Screening Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Global Blood Screening Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


  • Products Id :- DBMR743
  • |
  • Pages: 391
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Market Definition

Blood is an essential requirement for health care which helps in the proper functioning of the human body. A blood screening is defined as a medical process for the detection of disease. The process of blood screening is carried out for a variety of reasons in which the most common reason is pregnancy, human immunodeficiency (HIV) and blood type screenings. Screening of the blood may also be done to detect conditions such as general infections and cancer. Different types of assays are performed in detecting health related problems. Collected blood is screened with different techniques such as ELISA, NAT technology, next generation sequencing and many others. EIAs, particle agglutination (rapid tests) and (Chemiluminescence Immunoassays) CLIAs assays are used for blood screening. Most (Chemiluminescence Immunoassays) CLIAs consists greater specificity and sensitivity as compare to rapid tests that provides better result in screening process.

Global blood screening market is expected to reach with a healthy CAGR of 9.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation

By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Major growing sectors under the market segmentation are as follows:

In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.

In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.

In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today's world. The Blood screening method is found to be more useful for detecting cancer.

In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.

The key market players for global blood screening market are listed below:

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

TABLE OF CONTENTS

1 INTRODUCTION 30

1.1 OBJECTIVES OF THE STUDY 30

1.2 MARKET DEFINITION 30

1.3 OVERVIEW OF GLOBAL BLOOD SCREENING MARKET 30

1.4 CURRENCY AND PRICING 31

1.5 LIMITATION 32

1.6 MARKETS COVERED 32

2 MARKET SEGMENTATION 36

2.1 MARKETS COVERED 36

2.2 GEOGRAPHIC SCOPE 37

2.3 YEARS CONSIDERED FOR THE STUDY 38

2.4 CURRENCY AND PRICING 38

2.5 RESEARCH METHODOLOGY 39

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 42

2.7 DBMR MARKET POSITION GRID 43

2.8 THE CATEGORY VS TIME GRID 44

2.9 THE CATEGORY VS TIME GRID 45

2.10 DBMR MARKET CHALLENGE MATRIX 46

2.11 SECONDARY SOURCES 47

2.12 ASSUMPTIONS 47

3 MARKET OVERVIEW 48

3.1 DRIVERS 50

3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS 50

3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES 50

3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS 51

3.2 RESTRAINTS 52

3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES 52

3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS 52

3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES 53

3.3 OPPORTUNITIES 54

3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING 54

3.4 CHALLENGES 55

3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT 55

4 EXECUTIVE SUMMARY 56

5 PREMIUM INSIGHTS 60

6 GLOBAL BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES 63

6.1 OVERVIEW 64

6.2 REAGENTS & KITS 66

6.2.1 ELISA REAGENTS & KITS 68

6.2.1.1 IMMUNOSORBENTS 69

6.2.1.2 CONJUGATES 69

6.2.1.3 SUBSTRATES 69

6.2.1.4 CONTROLS 69

6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS 69

6.2.2 NAT REAGENTS & KITS 69

6.2.2.1 PROBES AND PRIMERS 70

6.2.2.2 ENZYMES AND POLYMERASES 70

6.2.2.3 LABELING AND DETECTION REAGENTS 70

6.2.2.4 STANDARDS AND CONTROLS 70

6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS 70

6.3 INSTRUMENTS 71

6.3.1.1 INSTRUMENTS, PRODUCT TYPE 72

6.3.1.1.1 SEMI AUTOMATED 72

6.3.1.1.2 AUTOMATED 72

6.3.1.2 INSTRUMENTS, PURCHASE TYPE 72

6.3.1.2.1 OUTRIGHT PURCHASE 72

6.3.1.2.2 RENTAL 72

6.4 SOFTWARE & SERVICES 73

7 GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY 74

7.1 OVERVIEW 75

7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 77

7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM 79

7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI) 79

7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA) 79

7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA) 79

7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS 79

7.2.2.1 FIRST-GENERATION ELISA 79

7.2.2.2 SECOND-GENERATION ELISA 79

7.2.2.3 THIRD-GENERATION ELISA 79

7.2.2.4 FOURTH-GENERATION ELISA 79

7.3 RAPID TESTS 80

7.4 NEXT-GENERATION SEQUENCING (NGS) 81

7.5 NUCLEIC ACID TEST 82

7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR) 83

7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) 83

7.6 WESTERN BLOT ASSAY 84

7.7 OTHERS 85

8 GLOBAL BLOOD SCREENING MARKET, BY DISEASE TYPE 86

8.1 OVERVIEW 87

8.2 ONCOLOGY 89

8.3 DIABETES MELLITUS 90

8.4 COLD & FLU 91

8.5 CHOLESTEROL 92

8.6 INFECTIOUS DISEASES 93

8.7 RESPIRATORY DISEASES 94

8.8 HIV/AIDS 95

8.9 OTHERS 96

9 GLOBAL BLOOD SCREENING MARKET, BY END USER 97

9.1 OVERVIEW 98

9.2 DIAGNOSTIC CENTERS 100

9.3 BLOOD BANK 101

9.4 HOSPITALS 102

9.5 CLINICS 103

9.6 AMBULATORY SURGICAL CENTERS 104

10 GLOBAL BLOOD SCREENING MARKET, BY GEOGRAPHY 105

10.1 OVERVIEW 106

10.2 NORTH AMERICA 111

10.2.1 U.S. 121

10.2.2 CANADA 128

10.2.3 MEXICO 135

10.3 EUROPE 142

10.3.1 GERMANY 153

10.3.2 U.K. 160

10.3.3 FRANCE 167

10.3.4 ITALY 174

10.3.5 SPAIN 181

10.3.6 SWITZERLAND 188

10.3.7 NETHERLANDS 195

10.3.8 BELGIUM 202

10.3.9 RUSSIA 209

10.3.10 TURKEY 216

10.3.11 REST OF EUROPE 223

10.4 ASIA-PACIFIC 224

10.4.1 CHINA 235

10.4.2 JAPAN 242

10.4.3 SOUTH KOREA 249

10.4.4 INDIA 256

10.4.5 SINGAPORE 263

10.4.6 AUSTRALIA 270

10.4.7 THAILAND 277

10.4.8 MALAYSIA 284

10.4.9 INDONESIA 291

10.4.10 PHILIPPINES 298

10.4.11 REST OF ASIA-PACIFIC 305

10.5 SOUTH AMERICA 306

10.5.1 BRAZIL 316

10.5.2 REST OF SOUTH AMERICA 323

10.6 MIDDLE EAST & AFRICA 324

10.6.1 SOUTH AFRICA 334

10.6.2 REST OF MIDDLE EAST & AFRICA 341

11 GLOBAL BLOOD SCREENING MARKET, COMPANY LANDSCAPE 342

11.1 COMPANY SHARE ANALYSIS: GLOBAL 342

11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 343

11.3 COMPANY SHARE ANALYSIS: EUROPE 344

11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 345

12 COMPANY PROFILES 346

12.1 F. HOFFMANN-LA ROCHE LTD 346

12.1.1 COMPANY OVERVIEW 346

12.1.2 REVENUEANALYSIS 346

12.1.3 COMPANY SHARE ANALYSIS 347

12.1.4 PRODUCT PORTFOLIO 347

12.1.5 RECENT DEVELOPMENT 348

12.2 ABBOTT 349

12.2.1 COMPANY OVERVIEW 349

12.2.2 REVENUE ANALYSIS 349

12.2.3 COMPANY SHAREV ANALYSIS 350

12.2.4 PRODUCT PORTFOLIO 350

12.2.5 RECENT DEVELOPMENT 351

12.3 THERMO FISHER SCIENTIFIC INC. 352

12.3.1 COMPANY OVERVIEW 352

12.3.2 REVENUE ANALYSIS 352

12.3.3 COMPANY SHAREV ANALYSIS 353

12.3.4 PRODUCT PORTFOLIO 353

12.3.5 RECENT DEVELOPMENTS 354

12.4 SIEMENS AG 355

12.4.1 COMPANY OVERVIEW 355

12.4.2 REVENUE ANALYSIS 355

12.4.3 COMPANY SHAREV ANALYSIS 356

12.4.4 PRODUCT PORTFOLIO 356

12.4.5 RECENT DEVELOPMENTS 358

12.5 BIO-RAD LABORATORIES, INC. 359

12.5.1 1.3.1COMPANY OVERVIEW 359

12.5.2 REVENUE ANALYSIS 359

12.5.3 COMPANY SHAREV ANALYSIS 360

12.5.4 PRODUCT PORTFOLIO 360

12.5.5 RECENT DEVELOPMENTS 362

12.6 BD 363

12.6.1 COMPANY OVERVIEW 363

12.6.2 REVENUE ANALYSIS 363

12.6.3 PRODUCT PORTFOLIO 364

12.6.4 RECENT DEVELOPMENTS 364

12.7 BECKMAN COULTER, INC. 365

12.7.1 COMPANY OVERVIEW 365

12.7.2 GEOGRAPHICPRESENCE 365

12.7.3 PODUCT PORTFOLIO 366

12.7.4 RECENET DEVELOPEMENTS 367

12.8 BIOMERIEUX SA 368

12.8.1 COMPANY OVERVIEW 368

12.8.2 REVENUE ANALYSIS 368

12.8.3 PRODUCT PORTFOLIO 369

12.8.4 RECENT DEVELOPMENT 370

12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION) 371

12.9.1 COMPANY OVERVIEW 371

12.9.2 GEOGRAPHIC PRESENCE 371

12.9.3 PRODUCT PORTFOLIO 372

12.9.4 RECENT DEVELOPMENT 373

?

12.10 ENZO BIOCHEM INC. 374

12.10.1 COMPANY OVERVIEW 374

12.10.2 REVENUE ANALYSIS 374

12.10.3 PRODUCT PORTFOLIO 375

12.10.4 RECENT DEVELOPMENTS 376

12.11 GRIFOLS INTERNATIONAL, S.A. 377

12.11.1 COMPANY OVERVIEW 377

12.11.2 REVENUE ANALYSIS 377

12.11.3 PRODUCT PORTFOLIO 378

12.11.4 RECENT DEVELOPMENTS 379

12.12 HOLOGIC INC. 380

12.12.1 COMPANY OVERVIEW 380

12.12.2 REVENUE ANALYSIS 380

12.12.3 PRODUCT PORTFOLIO 381

12.12.4 RECENT DEVELOPMENTS 381

12.13 IMMUCOR, INC. 382

12.13.1 COMPANY OVERVIEW 382

12.13.2 GEOGRAPHIC PRESENCE: 382

12.13.3 PRODUCT PORTFOLIO 383

12.13.4 RECENT DEVELOPMENTS 384

12.14 MERIDIAN BIOSCIENCE, INC. 385

12.14.1 COMPANY OVERVIEW 385

12.14.2 REVENUE ANALYSIS 385

12.14.3 PRODUCT PORTFOLIO 386

12.14.4 RECENT DEVELOPMENTS 387

12.15 ORTHO CLINICAL DIAGNOSTICS 388

12.15.1 COMPANY OVERVIEW 388

12.15.2 GEOGRAPHIC PRESENCE 388

12.15.3 PRODUCT PORTFOLIO 389

12.15.4 RECENT DEVELOPMENTS 390

13 RELATED REPORTS 391

LIST OF FIGURES

FIGURE 1 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION 36

FIGURE 2 GLOBAL BLOOD SCREENING MARKET: DATA TRIANGULATION 39

FIGURE 3 GLOBAL BLOOD SCREENING MARKET: DROC ANALYSIS 40

FIGURE 4 GLOBAL BLOOD SCREENING MARKET:BOTTOM UP APPROACH 41

FIGURE 5 GLOBAL BLOOD SCREENING MARKET:TOP DOWN APPROACH 41

FIGURE 6 GLOBAL BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS 42

FIGURE 7 GLOBAL BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID 43

FIGURE 8 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 44

FIGURE 9 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 45

FIGURE 10 GLOBAL BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX 46

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF

GLOBAL BLOOD SCREENING MARKET 49

FIGURE 12 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION 58

FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025 59

FIGURE 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025 60

FIGURE 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025 61

FIGURE 16 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 62

FIGURE 17 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017 64

FIGURE 18 GLOBAL BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017 75

FIGURE 19 GLOBAL BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017 87

FIGURE 20 GLOBAL BLOOD SCREENING MARKET: BY END USER, 2017 98

FIGURE 21 GLOBAL BLOOD SCREENING MARKET SNAPSHOT (2017) 107

FIGURE 22 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2017) 108

FIGURE 23 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2018 & 2025) 108

FIGURE 24 GLOBAL BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025) 109

FIGURE 25 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES (2018-2025) 109

FIGURE 26 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017) 111

FIGURE 27 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017) 112

FIGURE 28 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 112

FIGURE 29 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025) 113

FIGURE 30 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES

(2018 TO 2025) 113

FIGURE 31 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017) 142

FIGURE 32 EUROPE BLOOD SCREENING: BY COUNTRY (2017) 143

FIGURE 33 EUROPE BLOOD SCREENING: BY COUNTRY (2018 & 2025) 143

FIGURE 34 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025) 144

FIGURE 35 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) 144

FIGURE 36 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017) 224

FIGURE 37 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017) 225

FIGURE 38 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 225

FIGURE 39 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025) 226

FIGURE 40 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES

(2018 TO 2025) 226

FIGURE 41 SOUTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017) 306

FIGURE 42 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017) 307

FIGURE 43 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 307

FIGURE 44 SOUTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025) 308

FIGURE 45 SOUTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES

(2018 TO 2025) 308

FIGURE 46 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017) 324

FIGURE 47 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2017) 325

FIGURE 48 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2018 & 2025) 325

FIGURE 49 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025) 326

FIGURE 50 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET,

BY PRODUCTS & SERVICES (2018 TO 2025) 326

FIGURE 51 GLOBAL BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%) 342

FIGURE 52 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%) 343

FIGURE 53 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%) 344

FIGURE 54 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%) 345

LIST OF FIGURES

FIGURE 1 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION 36

FIGURE 2 GLOBAL BLOOD SCREENING MARKET: DATA TRIANGULATION 39

FIGURE 3 GLOBAL BLOOD SCREENING MARKET: DROC ANALYSIS 40

FIGURE 4 GLOBAL BLOOD SCREENING MARKET:BOTTOM UP APPROACH 41

FIGURE 5 GLOBAL BLOOD SCREENING MARKET:TOP DOWN APPROACH 41

FIGURE 6 GLOBAL BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS 42

FIGURE 7 GLOBAL BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID 43

FIGURE 8 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 44

FIGURE 9 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 45

FIGURE 10 GLOBAL BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX 46

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF

GLOBAL BLOOD SCREENING MARKET 49

FIGURE 12 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION 58

FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025 59

FIGURE 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025 60

FIGURE 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025 61

FIGURE 16 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 62

FIGURE 17 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017 64

FIGURE 18 GLOBAL BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017 75

FIGURE 19 GLOBAL BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017 87

FIGURE 20 GLOBAL BLOOD SCREENING MARKET: BY END USER, 2017 98

FIGURE 21 GLOBAL BLOOD SCREENING MARKET SNAPSHOT (2017) 107

FIGURE 22 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2017) 108

FIGURE 23 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2018 & 2025) 108

FIGURE 24 GLOBAL BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025) 109

FIGURE 25 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES (2018-2025) 109

FIGURE 26 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017) 111

FIGURE 27 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017) 112

FIGURE 28 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 112

FIGURE 29 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025) 113

FIGURE 30 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES

(2018 TO 2025) 113

FIGURE 31 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017) 142

FIGURE 32 EUROPE BLOOD SCREENING: BY COUNTRY (2017) 143

FIGURE 33 EUROPE BLOOD SCREENING: BY COUNTRY (2018 & 2025) 143

FIGURE 34 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025) 144

FIGURE 35 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) 144

FIGURE 36 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017) 224

FIGURE 37 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017) 225

FIGURE 38 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 225

FIGURE 39 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025) 226

FIGURE 40 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES

(2018 TO 2025) 226

FIGURE 41 SOUTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017) 306

FIGURE 42 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017) 307

FIGURE 43 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 307

FIGURE 44 SOUTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025) 308

FIGURE 45 SOUTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES

(2018 TO 2025) 308

FIGURE 46 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017) 324

FIGURE 47 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2017) 325

FIGURE 48 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2018 & 2025) 325

FIGURE 49 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025) 326

FIGURE 50 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET,

BY PRODUCTS & SERVICES (2018 TO 2025) 326

FIGURE 51 GLOBAL BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%) 342

FIGURE 52 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%) 343

FIGURE 53 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%) 344

FIGURE 54 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%) 345

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.

select a license
Single User License
USD 4200 INR 302064
Corporate User License
USD 5400 INR 388368

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com